Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.
Structure of Bovine CD46 Ectodomain
Journal article
Aitkenhead H. et al, (2023), Viruses, 15, 1424 - 1424
Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy.
Journal article
Ragonnet-Cronin M. et al, (2023), Nat Commun, 14
Accelerating drug target inhibitor discovery with a deep generative foundation model.
Journal article
Chenthamarakshan V. et al, (2023), Science advances, 9
Broadly neutralizing antibodies against COVID-19.
Journal article
Zhou D. et al, (2023), Current opinion in virology, 61
ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface
Preprint
Zhang P. et al, (2023)
Cryogenic electron ptychographic single particle analysis with wide bandwidth information transfer.
Journal article
Pei X. et al, (2023), Nature communications, 14
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK.
Journal article
Wei J. et al, (2023), Nature communications, 14
Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study.
Journal article
Närhi F. et al, (2022), The Lancet. Digital health, 4, e220 - e234
Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England
Journal article
Leclerc QJ. et al, (2021), BMC Health Services Research, 21
Stringent thresholds in SARS-CoV-2 IgG assays lead to under-detection of mild infections
Journal article
Eyre DW. et al, (2021), BMC Infectious Diseases, 21
Publisher Correction: Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.
Journal article
Redhead MA. et al, (2021), Scientific reports, 11
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study
Journal article
Russell CD. et al, (2021), The Lancet Microbe, 2, e354 - e365
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK
Journal article
Docherty AB. et al, (2021), The Lancet Respiratory Medicine, 9, 773 - 785
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study
Journal article
Drake TM. et al, (2021), The Lancet, 398, 223 - 237
Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study
Journal article
Drake TM. et al, (2021), The Lancet Rheumatology, 3, e498 - e506
Obesity, Ethnicity, and Risk of Critical Care, Mechanical Ventilation, and Mortality in Patients Admitted to Hospital with COVID‐19: Analysis of the ISARIC CCP‐UK Cohort
Journal article
Yates T. et al, (2021), Obesity, 29, 1223 - 1230
Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK
Journal article
Bloom CI. et al, (2021), The Lancet Respiratory Medicine, 9, 699 - 711
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
Journal article
Gupta RK. et al, (2021), The Lancet Respiratory Medicine, 9, 349 - 359
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
Journal article
Lumley SF. et al, (2021), New England Journal of Medicine, 384, 533 - 540
Hand-foot-and-mouth disease virus receptor KREMEN1 binds the canyon of Coxsackie Virus A10
Journal article
Zhao Y. et al, (2020), Nature Communications, 11